Intelligent Bio Solutions (INBS) and The Competition Financial Contrast

Intelligent Bio Solutions (NASDAQ:INBS – Get Free Report) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its competitors? We will compare Intelligent Bio Solutions to related businesses based on the strength of its profitability, analyst recommendations, earnings, risk, valuation, institutional ownership and dividends.

Institutional and Insider Ownership

33.0% of Intelligent Bio Solutions shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 2.8% of Intelligent Bio Solutions shares are held by insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Intelligent Bio Solutions and its competitors revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Intelligent Bio Solutions $4.22 million -$12.43 million -0.25
Intelligent Bio Solutions Competitors $1.89 billion $135.83 million 5.77

Intelligent Bio Solutions’ competitors have higher revenue and earnings than Intelligent Bio Solutions. Intelligent Bio Solutions is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Intelligent Bio Solutions and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Intelligent Bio Solutions -269.28% -150.00% -83.38%
Intelligent Bio Solutions Competitors -270.28% -155.47% -22.38%

Volatility & Risk

Intelligent Bio Solutions has a beta of 4.48, meaning that its share price is 348% more volatile than the S&P 500. Comparatively, Intelligent Bio Solutions’ competitors have a beta of 2.58, meaning that their average share price is 158% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings for Intelligent Bio Solutions and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Intelligent Bio Solutions 1 1 0 0 1.50
Intelligent Bio Solutions Competitors 4311 10598 18392 838 2.46

As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.52%. Given Intelligent Bio Solutions’ competitors stronger consensus rating and higher probable upside, analysts clearly believe Intelligent Bio Solutions has less favorable growth aspects than its competitors.

Summary

Intelligent Bio Solutions competitors beat Intelligent Bio Solutions on 10 of the 13 factors compared.

Intelligent Bio Solutions Company Profile

(Get Free Report)

Intelligent Bio Solutions Inc. is a medical technology company focused on non-invasive testing and diagnostic solutions. Its flagship offering is the Intelligent Fingerprinting Drug Screening System, which analyzes trace sweat collected from a person’s fingertips to screen for drugs. The system combines a portable reader with single-use fingerprint test cartridges. Its compact format is designed for use in settings such as workplaces, law enforcement, drug treatment and rehabilitation programs, and other organizations that conduct screening.

Receive News & Ratings for Intelligent Bio Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Bio Solutions and related companies with MarketBeat.com's FREE daily email newsletter.